As the global population continues to age and healthcare spending rises due to the rising frequency of infectious and chronic diseases, the demand for advanced healthcare solutions remains steadfast. Given the industry’s steady growth prospects, investors could buy quality biotech stocks Innoviva, Inc. (INVA), Genmab A/S (GMAB), and Alnylam Pharmaceuticals, Inc. (ALNY).
The expansion of healthcare infrastructure in emerging countries and the rapid growth of healthcare facilities and modernization is boosting the industry. The global biotechnology market is expected to grow at a CAGR of 12.8% until 2030.
